The Gross Margin of Hanx Biopharmaceuticals (Wuhan) Co Ltd (3378.HK) is 5.35%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2025-12-31 | 5.35% |
| 2024-12-31 | 5.35% |
| 2023-12-31 | 6.85% |
| 2021-12-31 | 9.02% |
| 2020-12-31 | 9.41% |
| 2019-12-31 | 9.29% |
| 2018-12-31 | 13.29% |
| 2017-12-31 | 15.04% |